A rapid HPLC/ESI-MS method for the quantitative determination of oridonin in rat plasma

Pharmazie

Volumn 61, Issue 9, 2006, Pages 757-759

  Xu, Wen ^a   Sun, Jin ^a   Zhang, Tingting ^a   Tang, Jingling ^a   Li, Haiyan ^a   Fang, Jinling ^a   Chen, Dawei ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUTANOL; HYDROXYBENZOIC ACID; METHANOL; ORIDONIN; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SEPARATION TECHNIQUE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DITERPENES; DITERPENES, KAURANE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHARMACEUTICAL SOLUTIONS; QUALITY CONTROL; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33748996502     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cai RC, Guo HF (2003) Clinical research of Donglingcao combine with UFT for the treatment of advanced lung cancer. Pract Clin J Integr Tradit Chin West Med 3: 12-13.
2. Hsieh TC, Wijeratne KE, Liang JY, Gunatilaka AL, Wu JM (2005) Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Bioph Res Comm 337: 224-231.
3. Liu JJ, Huang RW, Lin DJ, Wu XY, Wu XY, Lu HL, Pan XL, Peng J, Li MQ, Lin Q (2004a) Oridonin-induced apoptosis of Jurkat cells and its mechanism. Comp Clin Path 13: 65-69.
4. Liu JJ, Wu XY, Lu HL, Pan XL, Peng J (2004b) Inhibitory effect of oridonin on the proliferation of NB4 cells and its mechanism. Chin-Ger J Clin Oncol 3: 51-54.
5. Lu YH, Wu WX, Bai L, Yang HM, Yu XL (2001) Determination of oridonin in Donglingcao tablets by HPLC. Chin Pharm Aff 15: 47-48.
6. Shang ZC, Ren HY, Ji CR, Li JS, Miao MS, Li HL (1995) Clinical evaluation of complex Donglingcao buccal tablets for the treatment of acute tonsillitis. Henan TCM 15(3): 161-162.
7. Wang RL (1984) Clinical evaluation of Donglingcao for 31patents with liver cancer. Chin J Cancer 8: 50.
8. Wang RL, Fan KS, Fan QX, Ji ZC, Yue BY, Chen ST, Wang MW (1989) Clinical evaluation for 437 esophageal carcinoma patents. Chin J Integr Tradit West Med 9: 740-741.
9. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induces a caspase-independent but mitochondria- and MAPK dependent cell death in the murine fibrosarcoma cell line L929. Biol Pharm Bull 27: 1527-1531.
10. Zhang DR, Ren TC, Lou HX, Xing J (2005) The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles. Acta Pharm Sinica 40: 573-576.
11. Zuo HJ, Li D, Wu B, Gao HY, Wu LJ, Ikejima T (2005) Studies on the constituents of Rabdosia rubescens (Hemsl.) Hara and their antitumor ctivities in vitro. J Shenyang Pharm Univ 22: 258-262.